Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7-hydroxylase in rats with subtotal nephrectomy. Chronic renal failure is associated with hyperlipidemia and atherosclerosis. The mechanism responsible for the observed increase of serum cholesterol in chronic renal disease is not certain. The objective of the present study was to characterize the effect of induced renal failure on 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-C0A reductase) and cholesterol 7a-hydroxylase, the two rate determining enzymes of the cholesterol and bile acid biosynthetic pathways, respectively. Studies were carried out in rats with subtotal (75%) nephrectomy, which resulted in a marked elevation of blood urea nitrogen (371 44% of control, P < 0.001), and was accompanied by significant increases in the levels of serum cholesterol (133 7%, P < 0.005) and triglycerides (185 25, P < 0.01).
tein abnormalities have also been described in chronic renal failure including increased lipoprotein production [6] , decreased high density lipoprotein (HDL) cholesterol [9] , reduced plasma lecithin:cholesterol acyltransferase activity (LCAT) [10] , a defect in lipoprotein and hepatic lipases [11, 12] , and abnormal lipoprotein metabolism associated with low insulin levels [13] . While hypertriglyceridemia is the major lipid abnormality in chronic renal failure, elevation of serum cholesterol levels has also been reported [6] . The association of hyperlipidemia of chronic renal disease and accelerated atherosclerosis has generated a continued interest in the pathophysiology of this association.
Under normal circumstances, the liver is the principle organ responsible for the maintenance of total body cholesterol homeostasis. The contribution of abnormal hepatic cholesterol metabolism to the pathogenesis of hypercholesterolemia in chronic renal failure has not been thoroughly studied. Under physiologic circumstances, cholesterol homeostasis in the liver is maintained by a coordinate regulation of HMG-CoA reductase, the rate limiting enzyme in the cholesterol biosynthetic pathway, cholesterol 7cr-hydroxylase, the rate-limiting enzyme in the bile acid biosynthetic pathway, acyl CoA:cholesterol acyltransferase (ACAT), the enzyme which esterifies free cholesterol, cholesteryl ester hydrolase (CEH), an enzyme which hydrolyzes cholesterol esters, the low density lipoprotein (LDL) receptors, responsible for removal of tissue cholesterol [14] , and biliaiy cholesterol secretion, which represents about 50% of cholesterol removed each day [15] .
The main objective of the present study was to establish whether alterations of hepatic cholesterol metabolism occur in the early phase of renal failure. We first established that subtotal nephrectomy resulted in elevation of serum triglycerides and cholesterol levels, the two major abnormalities observed in patients with renal failure. Next, we examined the behavior of HMG-CoA reductase and cholesterol 7cr-hydroxylase, the two enzymes which determine the rates of cholesterol synthesis and degradation. We found that the specific activities of HMG-CoA reductase and cholesterol 7cr-hydroxylase were increased two to three fold and that up-regulation of both of these enzymes occurred at the post-transcriptional level. The net effect of these changes of hepatic lipid metabolism on cholesterol homeostasis has not been ascertained in this study. controlled lighting conditions on a natural light-dark cycle (0600-1800 light phase). Groups of age-and weight-matched animals were used in all experiments. Surgeries were performed in two stages using methoxyfiurane anesthesia. On day 0, the left kidney was exposed and decapsulated in all rats. The upper and lower thirds of the organ were excised in the nephrectomy group only. On day 7, the right kidney was exposed and decapsulated in all rats and excised in the nephrectomy group only. After surgery, animals were placed in individual metabolic cages with free access to water and laboratory chow. All rats were pair fed, receiving the same diet, powdered rat chow modified to contain 35.3% casein. Protein supplementation was provided to exacerbate the uremic state in nephrectomy animals while ensuring normal protein intake in sham operated controls. Animals were sacrificed by decapitation on day 21 after second surgery. Just prior to sacrifice, under brief methoxyflurane anesthesia, biliary cannula were placed and a 20 minute collection of bile was obtained for analysis of biliary bile acid, cholesterol, and phospholipid secretion. At the conclusion of the experiment, animals were sacrificed (between 9 and 10 a.m.), livers were harvested and four one gram pieces were removed. Two pieces were used to extract total RNA, and two pieces to isolate nuclei. The remainder of the liver was used in the preparation of microsomes as previously described [16] .
Determinations of serum parameters
Laboratory values for blood urea nitrogen and serum cholesterol, triglycerides, albumin, aspartate aminotransferase (AST), Microsomal HMG-CoA reductase specific activity was assayed by the method of Whitehead et al [17] . The specific activity of cholesterol 7cs-hydroxylase was determined in microsomes using a high performance liquid chromatography (HPLC) assay procedure as described previously by us [18] .
Determination of mRNA levels and transcriptional activity for HMG-CoA reductase, cholesterol 7c-hydroxylase, and low density lipoprotein receptor
Methods used for the isolation of mRNA and hepatic nuclei have been recently described in great detail as have our techniques for dot blot hybridization and nuclear run-on assays [191.
The absorbencies for hybridization to cholesterol 7o-hydroxylase (pBSK 7a6), HMG-CoA reductase (pRED 227), and low density lipoprotein receptor (LDL-R) as standardized to albumin pRSA 57 were determined for each condition, and the resulting indices were compared to the control animals. In order to insure that albumin transcriptional activity was unaffected by experimental manipulation (75% nephrectomy), albumin transcriptional rates were also standardized to cyclophilin (plBl5). Cyclophilin is a cytosolic protein which binds cyclosporin [20] . No differences in the transcriptional activity of albumin was noted between the control and uremic state when standardized to cyclophilin.
Determination of microsomal cholesterol
Microsomal free cholesterol was determined by the method of Abell et al [21] .
Statistical analysis
Statistical differences between groups were tested by means of Students's t-test for unequal samples.
Results
Effect of 75% nephrectomy on animal weight gain Mean pre-and end-study animal weights were not significantly different in control versus 75% nephrectomy animals ( Table 1) . Both control rats and nephrectomized rats ate similar quantities of chow and had almost identical weight gain suggesting that experimental rats completed the study in a good nutritional state. Mean control values: 0.83 0.06 ml/hr; b 32.7 6.3 mol/ml; C 0.38 0.04 .rmol/hr-100 g rat; ' 0.16 0.03 xmol/hr-100 g rat Effect of 75% nephrectomy on blood urea nitrogen, serum cholesterol, triglycerides, albumin, aspartate aminotransferase (Ast), and alanine aminotransferase (Alt) Table 2 demonstrates that 75% nephrectomy led to a 371% increase in the blood urea nitrogen (P < 0.001), 185% increase in serum triglyceride values (P < 0.005), and a 133% increase in serum cholesterol (P < 0.01). Microsomal cholesterol was also markedly increased (150 13%) over controls (P < 0.01). Serum albumin, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were not significantly different from controls. These experiments show these elevations of plasma lipids occur without any evidence of gross liver injury.
Effect of 75% nephrectomy on bile flow, bile acid concentration, and biliaiy cholesterol and phospholipid secretion At the conclusion of the study, a 20 minute collection of bile was obtained for analysis of bile flow and biliary lipid composition (Table 3) . Bile flow and bile acid concentration in rats that had undergone 75% nephrectomy were not significantly different from sham operated controls. In rats with subtotal nephrectomy, cholesterol and phospholipid secretion increased by 166 13% and 201 31%, respectively. These differences were statistically significant (P < 0.01 and P < 0.03). Effect of 75% nephrectomy on the specific activities, steady-state mRNA levels, and transcriptional activities of HMG-CoA reductase, cholesterol 7a-hydroxylase, and of the low density lipoprotein receptor activity A 2.2-fold increase (P < 0.02) in the specific activity of HMG-CoA reductase and a 2.4-fold increase (P < 0.05) in cholesterol 7a-hydroxylase specific activity were observed in nephrectomized (uremic) rats as compared to sham operated controls (Table 4) . Steady-state mRNA levels were quantitated using total RNA (0.6 to 10 gig) blotted onto nitrocellulose membranes, as previously described in detailed by Pandak et al [19] . HMGCoA reductase and cholesterol 7a-hydroxylase steady-state mRNA levels by dot blot analysis ( Fig. 1 and Table 4) were not significantly different from sham operated controls. As described in the Methods section, the absorbencies for hybridization to HMG-CoA reductase, cholesterol 7cs-hydroxylase and LDL receptor as compared to albumin were determined for each condition, and the resulting indices were compared to the control animals. Figure 2 demonstrates a representative nuclear run-on assay for cholesterol 7a-hydroxylase (line A), HMG-CoA reductase (line C), and albumin (line B). The ratio of transcriptional activity of the HMG-CoA reductase and LDL (Table 4) to that of the albumin gene was not significantly altered by 75% nephrectomy. However, 75% nephrectomy led to a 44% decrease (P < 0.01) in the transcriptional activity of cholesterol 7cs-hydroxylase as compared to controls.
The nuclear run-on assay is an accepted and frequently used method to estimate gene transcriptional activity. The assay refleets transcriptional activity in vivo. In the nuclear run-on assay nascent RNA transcripts are allowed to elongate in the presence of nucleotides of which one is labeled with [a-32P]. In order to account for variations in [32P] uptake and incorporation by the nuclei, number of nuclei, and amount of labeled nucleotide added, the RNA transcripts were also hybridized to albumin (pRSA) and cyclophilin (plBl5), which serves as an internal control. The comparison of the transcriptional activity of the gene of interest with an appropriate standard is a routine practice when determining transcriptional activity. The in vivo transcriptional activity is calculated from cholesterol 7cs-hydroxylase/albumin ratio by laser densitometry over the range of concentrations. or cyclophilin (plBl5) that yields the quantitation of mRNA or gene transcription. Figure 3 demonstrates a composite of specific activities, steadystate levels of mRNA and the transcriptional activities of HMGCoA (HMG-R) and cholesterol 7n-hydroxylase (C7csH) expressed as percent control. There was a twofold increase in HMG-CoA reductase and cholesterol 7a-hydroxylase activities which was not coupled with parallel increases of steady-state Discussion There is a growing awareness that hyperlipidemia in several types of renal disease represents a significant risk factor for coronary heart disease [22] .A classical example of this association are patients with nephrotic syndrome, who develop marked hypercholesterolemia relatively early in the course of their disease [23] . Recently, these patients have been shown to have elevated levels of Lp(a) lipoprotein which has thrombogenic and atherogenic properties [24] . For these reasons, the reduction of hypercholesterolemia in the nephrotic syndrome has been an important therapeutic goal, as elevated cholesterol levels appear to be associated with worsening of renal and coronary heart disease. Indeed, in the nephrotic syndrome, administration of lovastatin resulted in prevention of glomerulosclerosis and uremia [26] .
In contrast to nephrotic syndrome, chronic renal failure in humans is associated with marked increases in serum total triglycerides and very low density lipoproteins [1, 6] . The hypertriglyceridemia found in patients with chronic renal disease has been attributed to defective lipoprotein clearance [27] [28] [29] , which is thought to occur as a result of a decrease in lipoprotein and hepatic lipases, and in the plasma activity of lecithin:cholesterol acyltransferase [10] [11] [12] . These patients were also described to have somewhat less pronounced abnormalities of cholesterol metabolism manifested as hypercholesterolemia [6] , and a decrease in total high density apoprotein (HDL) and HDL2 cholesterol levels [30, 31] . The mechanism responsible for hypercholesterolemia in chronic renal disease has not been clearly defined and changes in hepatic cholesterol metabolism have not been systematically studied. The present study was designed to provide information on the effects of renal failure on hepatic cholesterol metabolism.
Partially nephrectomized rats have been previously used to study various metabolic alterations in chronic renal failure [32] [33] [34] . In the present study, partially nephrectomized rats ate normally and gained weight while developing chronic renal failure manifested by a fourfold increase in blood urea nitrogen. After three weeks, rats with subtotal nephrectomy demonstrated a marked increase in serum triglyceride and cholesterol levels, suggesting that this experimental model could be used to simulate chronic renal failure in humans. As in chronic renal failure, elevation of serum triglycerides was more pronounced than elevation of serum cholesterol.
The results of the present study demonstrate that HMG-CoA reductase specific activity, which is often taken as an index of cholesterol synthesis, was increased more than twofold in rats with partial nephrectomy and uremia. This was a surprising observation since in the presence of elevated levels of serum cholesterol and increased hepatic microsomal cholesterol concentration, the HMG-CoA reductase specific activity would be expected to be suppressed rather than stimulated [35] . Thus, it appears that normal feedback regulation of HMG-CoA reductase is altered in partially nephrectomized rats with induced renal failure. HMGCoA reductase steady-state levels of mRNA and gene transcriptional activity were unchanged as compared to controls. These findings suggest that in the experimentally induced renal failure in the rat, the observed increase in HMG-CoA reductase specific activity may be due to an alteration in enzyme catalytic activity, that is, altered phosphorylation-dephosphorylation [36] [37] [38] or changes in the membrane fluidity [39] . These data are consistent with observations of Ness, Keller and Pendelton [40] who have recently reported that in the rat, feedback regulation of HMGCoA reductase by dietary cholesterol may not be due to altered mRNA levels as previously thought. However, even in that study the specific activity of HMG-CoA reductase was suppressed by cholesterol. Therefore, the findings of the present study suggest that in renal failure there is an alteration of feedback regulation of HMG-CoA reductase. Alternatively, these changes could be due to alteration in protein synthesis and/or degradation.
Bile acid synthesis from cholesterol is a major pathway for elimination of cholesterol from the body. Approximately, 50% of cholesterol eliminated from the body each day is catabolized in the liver to primary bile acids via a number of intermediary steps. The remaining cholesterol is removed from the body via canalicular secretion of cholesterol [13] . Cholesterol 7a-hydroxylase, a cytochrome P-450 monooxygenase is located in the hepatocyte smooth endoplasmic reticulum. This enzyme has been recently purified, characterized and cloned by several investigators, providing for the first time, the opportunity to study molecular basis of its regulation under physiologic and pathophysiologic circumstances [41] [42] [43] . The major physiologic regulators of cholesterol 7n-hydroxylase activity appear to be cholesterol [19] , certain hormones such as dexamethasone and thyroxine [44] and hydrophobic bile salts [45] [46] [47] , all acting at the level of gene transcription [19, 48] . Under physiologic and pharmacologic conditions, HMG-CoA reductase and cholesterol 7o-hydroxylase specific activities change in tandem as if they are responding to the same regulatory signal [14, 47] . The increase in HMG-CoA reductase specific activity appears to precede the increase in cholesterol 7a-hydroxylase activity. This latter finding suggests that the newly synthesized cholesterol may play a role in the regulation of cholesterol 7a-hydroxylase. These conclusions were recently confirmed by Pandak et al [19] , who have shown that inhibition of cholesterol synthesis with lovastatin results in a prompt and profound down-regulation of cholesterol 7a-hydroxylase activity. This effect can be prevented by a continuous infusion of mevalonate, a precursor of cholesterol. Furthermore, Jones et al [49] have recently shown that infusion of mevalonate increases cholesterol 7s-hydroxylase steady-state mRNA and transcriptional activity, while a single injection of lovastatin, a competitive inhibitor of HMG-CoA reductase, decreases cholesterol 7a-hydroxylase mRNA and transcriptional activity. The data obtained in the present study indicate that in uremia, the interrelationship between cholesterol and bile acid synthesis is maintained, that is, both appeared to be increased to a similar extent. The increase in cholesterol 7a-hydroxylase activity (bile acid synthesis) is most likely driven by increased availability of newly synthesized cholesterol, which appears to be a major regulator of this enzyme. Since the observed magnitude of increases in HMG-CoA reductase and cholesterol 7a-hydroxylase specific activities were almost identical, one is tempted to speculate that most of the newly synthesized cholesterol is converted to bile acids rather than diverted to the formation of very low density lipoproteins. Interestingly, the specific activities of both enzymes were increased in the presence of unaltered mRNA and normal or decreased gene transcriptional activity. In this regard, the mechanism of regulation of cholesterol 7n-hydroxylase in renal failure departs from experimental findings in normal rats, in which the enzyme is up-regulated by cholesterol at the transcriptional level [48] . The additional factor(s) responsible for these differences in the regulation of cholesterol 7cv-hydroxylase have not been identified in this study.
In summary, we have provided evidence that in early renal failure, the specific activities of HMG-CoA reductase and cholesterol 7a-hydroxylase are increased twofold. The primary event appears to be a paradoxical increase in HMG-CoA reductase specific activity. Almost identical increases in cholesterol 7cs-hydroxylase activity are likely caused by the availability of newly synthesized cholesterol.
